CD8A and neoplasm: Better response to checkpoint inhibitors (CPI) was observed in tumors with higher density of CD8 T cells at the center and periphery of a tumor, whereas immune evasion through reduction or loss of HLA expression on tumor or metastases may reduce response to CPI.